Molecular Aspects of Cervical Cancer Screening
G. Denice Smith, PhD, CT (ASCP)
Presentation date: January 22, 2013; Expires: January 22, 2016
The role for molecular testing in cervical cancer screening continues to be discussed and debated in cytology. This webinar will summarize current molecular test options for cervical cancer screening, including tests for the presence or integration status of HPV, p16, and additional markers. Opportunities/barriers to cytotechnologist involvement will be addressed.